Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Nervous System Diseases

At Risk for Huntington's Disease

2018

Articles 1 - 16 of 16

Full-Text Articles in Medicine and Health Sciences

Roche Announces U.S., Canada Sites For Phase 3 Clinical Trial Of Huntington's Disease Drug, Kenneth P. Serbin Dec 2018

Roche Announces U.S., Canada Sites For Phase 3 Clinical Trial Of Huntington's Disease Drug, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.


Building Solidarity In Disease Communities’ Quest For Better Care And Treatments: A Conversation With A Young Tennis Award-Winner, Kenneth P. Serbin Dec 2018

Building Solidarity In Disease Communities’ Quest For Better Care And Treatments: A Conversation With A Young Tennis Award-Winner, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.


This Thanksgiving, Appreciating Stable Health And New Plans For Huntington's Disease Advocacy, Kenneth P. Serbin Nov 2018

This Thanksgiving, Appreciating Stable Health And New Plans For Huntington's Disease Advocacy, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.


Roche Announces First Sites For Key Huntington’S Disease Observational Study, Kenneth P. Serbin Nov 2018

Roche Announces First Sites For Key Huntington’S Disease Observational Study, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.


Unpacking Generation Hd1, The Roche Phase 3 Huntington's Disease Clinical Trial, Kenneth P. Serbin Sep 2018

Unpacking Generation Hd1, The Roche Phase 3 Huntington's Disease Clinical Trial, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.


Roche Phase 3 Clinical Trial For Huntington’S Disease Gene-Slicing Drug To Enroll Volunteers In Early 2019, Kenneth P. Serbin Sep 2018

Roche Phase 3 Clinical Trial For Huntington’S Disease Gene-Slicing Drug To Enroll Volunteers In Early 2019, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.


In Harriet’S Tragic Death, The Vulnerability Caused By Huntington's Disease – But Also The Story Of A Beautiful Soul, Kenneth P. Serbin Jul 2018

In Harriet’S Tragic Death, The Vulnerability Caused By Huntington's Disease – But Also The Story Of A Beautiful Soul, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.


Free From The Threat Of Huntington’S Disease, Our 'Miracle Baby' Turns 18, Kenneth P. Serbin May 2018

Free From The Threat Of Huntington’S Disease, Our 'Miracle Baby' Turns 18, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.


New Ionis Data Show Positive Trends In Clinical Measures Of Huntington's Disease Drug Trial Volunteers, Kenneth P. Serbin Apr 2018

New Ionis Data Show Positive Trends In Clinical Measures Of Huntington's Disease Drug Trial Volunteers, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.


Nora Guthrie: We’Re All ‘Hoping Machines’ In The Fight Against Huntington's Disease, Kenneth P. Serbin Apr 2018

Nora Guthrie: We’Re All ‘Hoping Machines’ In The Fight Against Huntington's Disease, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.


Roche Gears Up For Pivotal Phase 3 Huntington’S Disease Gene-Slicing Clinical Trial, Kenneth P. Serbin Mar 2018

Roche Gears Up For Pivotal Phase 3 Huntington’S Disease Gene-Slicing Clinical Trial, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.


In Chronicling The Quest To Cure Huntington’S Disease, A Whirlwind Of Emotions, Kenneth P. Serbin Mar 2018

In Chronicling The Quest To Cure Huntington’S Disease, A Whirlwind Of Emotions, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.


The Best News For The Huntington's Disease Community Since The Discovery Of The Gene: Ionis Trial Data Revealed, Roche Confirms Jump To Phase 3, Kenneth P. Serbin Mar 2018

The Best News For The Huntington's Disease Community Since The Discovery Of The Gene: Ionis Trial Data Revealed, Roche Confirms Jump To Phase 3, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.


Overflow Audience At 13th Annual Huntington's Disease Therapeutics Conference, Kenneth P. Serbin Feb 2018

Overflow Audience At 13th Annual Huntington's Disease Therapeutics Conference, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.


Chdi's 13th Conference Promises Some Good News For The Huntington's Disease Community, Kenneth P. Serbin Feb 2018

Chdi's 13th Conference Promises Some Good News For The Huntington's Disease Community, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.


Faith In Each Other: Sticking Together Through The Challenges Of Huntington's Disease, Kenneth P. Serbin Feb 2018

Faith In Each Other: Sticking Together Through The Challenges Of Huntington's Disease, Kenneth P. Serbin

At Risk for Huntington's Disease

No abstract provided.